Vildagliptin Versus α-Glucosidase Inhibitor as Add-On to Metformin for Type 2 Diabetes: Subgroup Analysis of the China Prospective Diabetes Study

INTRODUCTION: The effect of dipeptidyl peptidase-4 (DDP-4) inhibitors versus α-glucosidase inhibitors (AGIs) on the treatment of type 2 diabetes mellitus (T2DM) in a real-world setting is unknown. The aim of this real-world study was to compare the glucose-lowering effect and tolerability of vildagl...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Diabetes Ther
Päätekijät: Chen, Yulong, Li, Quanmin, Han, Ying, Ji, Hongmei, Gu, Mingjun, Bian, Rongwen, Ding, Weiguang, Cheng, Jian, Mu, Yiming
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer Healthcare 2019
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6965535/
https://ncbi.nlm.nih.gov/pubmed/31823167
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-019-00742-8
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia